ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2310건의 자료가 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
1547 | Completed | Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients | Covid-19 | Drug: Antroquinonol Other: Placebo |
Phase 2 | Golden Biotechnology Corporation | INDUSTRY | 124 | All | 18 Years ~ 80 Years | Franciscan Health Michigan City, Michigan City, Indiana, United States Ascension.Via Christi Research, Wichita, Kansas, United States Adventist Healthcare Shady Grove Medical Center, Rockville, Maryland, United States South Jersey Infectious Disease, Somers Point, New Jersey, United States Duke University Southeastern Health, Lumberton, North Carolina, United States Centro Gallego, Buenos Aires, Capital Federal, Argentina Clinica de los Virreyes, Buenos Aires, Capital Federal, Argentina Sanatorio Privado Mayo SA, Cordoba, Ciudad De Cordoba, Argentina Hospital Rawson, Cordoba, Cuidad De Cordoba, Argentina Clinica Viedma SA, Viedma, Pcia De Rio Negro, Argentina Clinica Internacional S.A. - Sede Lima, Lima Cercado, Lima, Peru Unidad de Investigacion, Hospital Nacional IV Alberto Sabogal Sologuren-Essalud, Red Assitencial Sabogal, Callao, Peru Hospital de Chancay, Chancay, Peru Asociacion Civil Selva Amazonica, Iquitos, Peru Hospital III Daniel Alcides Carrion - EsSalud, Tacna, Peru |
1546 | Completed | Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects | Pneumonia, Viral | Drug: Fostamatinib Drug: Placebo |
Phase 3 | Rigel Pharmaceuticals | INDUSTRY | 280 | All | 18 Years ~ 100 Years | University of California Irvine, Orange, California, United States George Washington University Hospital, Washington, District of Columbia, United States Alternative Research Associates, LLC, Hialeah, Florida, United States Alternative Research Associates, LLC, Miami, Florida, United States Loyola University Medical School, Maywood, Illinois, United States Harvard Medical School- Bringham and Women's Hospital, Boston, Massachusetts, United States Henry Ford, Detroit, Michigan, United States Ascension Medical Group- St. John Clinic Infectious Disease, Tulsa, Oklahoma, United States Houston Methodist Research Institute, Houston, Texas, United States Clinica Chutro, Cordoba, CP, Argentina Hospital Lencinas, Godoy Cruz, Mendoza, Argentina Corporacion Medica de General San Martin, San Martin, Provincia De Buenos Aires, Argentina Hospital de Alta Complejidad Cuenta Alta, Buenos Aires, Argentina Hospital Del Bicentenario - Dr. Luis Federico Leloir, Buenos Aires, Argentina Clinica Zabala, Buenos Aires, Argentina Clinica Adventista Belgrano, Buenos Aires, Argentina Clinica Monte Grande, Buenos Aires, Argentina Hospital de Infecciosas Dr.Francisco Javier Muniz, Buenos Aires, Argentina Sanatorio Guemes, Buenos Aires, Argentina Sanatorio Sagrado Corazon, Buenos Aires, Argentina Hospital San Roque, Cordoba, Argentina Sanatorio Mayo Privado, Cordoba, Argentina Hospital das Clinicas da Universidade Federal de Goias (HC/UFG), Goiania, Goias, Brazil Hospital Luxenburgo-Associacao Mario Penna, Belo Horizonte, Minas Gerais, Brazil Hospital Universitario de Maringa, Maringa, Parana, Brazil Hosp. Angelina Caron, Campina Grande do Sul, Parana, Brazil Irmandade da Santa Casa de Misericordia de Porto Alegre - ISCMPA, Porto Alegre, Rio Grande Do Sul, Brazil Hospital des clinicas de porto alegre - Centro de pequisas clinicas, Porto Alegre,, RS, Brazil Complexo de Prevencao, Diagnostico, Terapia e Reabilitacao Respiratoria LTDA, Blumenau, Santa Catarina, Brazil Hospital Alemao Oswaldo Cruz (HAOC), Bela Vista, Sao Paolo, Brazil Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP), Campinas, Sao Paolo, Brazil Hospital Bandeirantes (LeForte), Liberdade, Sao Paolo, Brazil Hospital Universitario Sao Francisco na Providencia de Deus, Braganca Paulista, Sao Paulo, Brazil Clinica de Alergia Martti Antila S/S Ltda, Sorocaba, Sao Paulo, Brazil Fundacao Faculdade Reg. de Med de SJRP, Sao Jose Do Rio Preto, Sao Paulo, Brazil Star Medica Vivo Bicentenario, Nezahualcoyotl, Mex, Mexico Unidad Medica para la Salud Integral (UMSI), Monterrey, Nuevo Leon, Mexico Kohler & Milstein Research, Merida, Yucatan, Mexico Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico Icaro Investigaciones en Medicina, Chihuahua, Mexico Nuevo Hospital Civil de Guadalajara, Guadalajara, Mexico Centro Medico Issemym Toluca, Metepec, Mexico The American British Cowdray Medical Center I.A.P., Mexico City, Mexico Hospital Angeles Roma, Mexico, Mexico CEPREP Centro de Prevencion y Rehabilitacion de Enfermedades Pulmonares Cronicas, Nuevo Leon, Mexico Hospital Civil de Culiacan, Sinaloa, Mexico Hospital Civil de Culiacan, Sinaloa, Mexico |
1545 | Completed | Dual MRI for Cardiopulmonary COVID-19 Long Haulers | Covid19 | Drug: Hyperpolarized 129Xenon gas | Phase 2 | Bastiaan Driehuys | OTHER | 18 | All | 18 Years | Duke Asthma, Allergy, and Airway Center, Durham, North Carolina, United States |
1544 | Unknown status | Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 | COVID-19 | Drug: Interferon beta-1b Drug: Clofazimine |
Phase 2 | The University of Hong Kong | OTHER | 81 | All | 18 Years | The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong, China |
1543 | Completed | Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19) | COVID-19 | Drug: Duvelisib Drug: Placebo |
Phase 2 | Emory University, Verastem, Inc. | OTHER | 47 | All | 18 Years | Emory Saint Joseph's Hospital, Atlanta, Georgia, United States Emory University Hospital Midtown, Atlanta, Georgia, United States Emory University Hospital, Atlanta, Georgia, United States |
1542 | Completed | Duvelisib to Combat COVID-19 | COVID-19 | Drug: Duvelisib Procedure: Peripheral blood draw Drug: Placebo |
Phase 2 | Washington University School of Medicine, Verastem, Inc. | OTHER | 28 | All | 18 Years | Washington University School of Medicine, Saint Louis, Missouri, United States |
1541 | Withdrawn | DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19) | COVID19 | Drug: Doxycycline Drug: Placebo |
Phase 3 | Nantes University Hospital | OTHER | 0 | All | 46 Years | CHU Avicenne - APHP, Bobigny, France CHU Bordeaux, Bordeaux, France CHU Caen, Caen, France CHU Dijon, Dijon, France CHU Grenoble, Grenoble, France CHU Nantes, Nantes, France |